The report on global
transcriptomics technologies market is an in depth analysis of the segments and
sub-segments in the transcriptomics technologies market. The report provides analysis
for the global as well as regional markets over the period of 2015 to 2023.
According to report the global transcriptomics technologies market is expected
to grow at a CAGR of 11% over the forecast period of 2017 - 2023.
Figure : Global Transcriptomics Technologies Market by Value 2015
– 2023
Segments Covered
The report on global
transcriptomics technologies market covers segments such as technology,
application and end-user. The technology segments include next generation
sequencing, microarray, gene regulation technologies and PCR. On the basis of
application, the global transcriptomics technologies market is categorized into
bioinformatics, clinical diagnostics, comparative transcriptomics and drug
discovery and research. Furthermore, on the basis of end-user the
transcriptomics technologies market is segmented as academic research and
pharmaceutical and biotech companies.
Geographic Coverage
The report provides
regional analysis covering geographies such as North America, Europe,
Asia-Pacific, and Rest of the World. In this section the key trends and market
size for each geography is provided over the period of 2015 – 2023.
The countries covered in
the North America region include the U.S., Canada, and Mexico; while
Asia-Pacific includes China, Japan, India, South Korea, Malaysia and among
others. The U.S. drives the grwoth in the North America region as it is the
largest market in the region. The Asia-pacific region offers a substantial
potential for the market growth owing to rapid growth in markets such as India
and China. The APAC region is projected to experience a growth at a CAGR of
x.x% over the period of 2017 - 2023.
Companies Profiled:
The report provides
profiles of the companies in the global transcriptomics technologies market
such as, Thermo Fisher Scientific, Sigma Aldrich Corporation, Qiagen N. V.,
Fluidigm Corporation , Life Technologies Corporation, Illumina Inc., F.
Hoffmann La Roche Ltd, Danaher Corporation, Bio-Rad Laboratories, and Agilent
Technologies Inc. .
Report Highlights:
The report provides deep
insights on demand forecasts, market trends and micro and macro indicators. In
addition, this report provides insights on the factors that are driving and
restraining the global transcriptomics technologies market. Moreover,
IGR-Growth Matrix analysis given in the report brings an insight on the
investment areas that existing or new market players can consider.
The report provides
insights into the market using analytical tools such as Porter’s five forces
analysis and DRO analysis of transcriptomics technologies market. Moreover, the
study highlights current market trends and provides forecast from 2017 to 2023.
We also have highlighted future trends in the transcriptomics technologies
Market that will impact the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight on the
market share of the leading players. Additionally, the analysis highlights rise
and fall in the market shares of the key players in the market.
This report will help
manufacturers, suppliers and distributors of the transcriptomics technologies
market to understand the present and future trends in this market and formulate
their strategies accordingly.
Please Choose One of them.